Brief: Clinuvel Pharmaceuticals
Corporate news snapshot for Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals (CUV) has obtained positive results from an experimental randomised placebo-controlled Phase II trial evaluating the photoprotective effect of afamelanotide in 16 patients.
Loading...
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles